Literature DB >> 32512107

Renal Oncocytoma: An Algorithm for Diagnosis and Management.

Maher Abdessater1, Anthony Kanbar2, Eva Comperat3, Adrien Dupont-Athenor2, Louise Alechinsky4, Martin Mouton2, Philippe Sebe2.   

Abstract

Renal oncocytoma is an uncommon tumor that exhibits numerous features which are characteristic but not necessarily unique. Percutaneous biopsy is a safe method of diagnosis. However, differentiation from other tumor subtypes often requires sophisticated analysis and is not universally feasible. This is why, surgical management can be considered as a first-line treatment or after surveillance. Potential triggers for change in management are: tumor size >3 cm, stage progression, kinetics of size progression (>5 mm/y), and clinical change in patient or tumor factors. Long-term follow-up data are lacking and greater centralization should be considered to reach adequate management.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32512107     DOI: 10.1016/j.urology.2020.05.047

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

Review 1.  Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled Analysis.

Authors:  Michael Baboudjian; Daniel Moser; Takafumi Yanagisawa; Bastien Gondran-Tellier; Eva M Compérat; Damien Ambrosetti; Laurent Daniel; Cyrille Bastide; Shahrokh F Shariat; Eric Lechevallier; Pietro Diana; Alberto Breda; Benjamin Pradere; Romain Boissier
Journal:  Eur Urol Open Sci       Date:  2022-05-19

2.  Eosinophilic Vacuolated Tumor of Kidney: Clinical Perspective of a New Pathologic Emerging Entity.

Authors:  İbrahim Kartal; Halil Ibrahim Ivelik; Şeref Çoşer; Hazal Tunç; Mustafa Fuat Açıkalın
Journal:  Cureus       Date:  2022-05-04

3.  High-Resolution Ultrasonography of Renal Oncocytoma Presenting with Symptomatic Hematuria and Urinary Bladder Clot Retention-A Rare Occurrence.

Authors:  Reddy Ravikanth
Journal:  J Kidney Cancer VHL       Date:  2022-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.